MoneyWorks4Me

Eiko Lifesciences informs about revised disclosures

17 May 2022 Evaluate

Eiko Lifesciences has informed that the Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..